CRIS Current Research Information System

DE PONTI, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.868
AS - Asia 12.729
EU - Europa 10.167
AF - Africa 816
Continente sconosciuto - Info sul continente non disponibili 785
SA - Sud America 756
OC - Oceania 39
Totale 41.160
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.619
SG - Singapore 3.472
VN - Vietnam 3.164
CN - Cina 2.955
IT - Italia 2.671
GB - Regno Unito 2.337
DE - Germania 1.198
HK - Hong Kong 1.154
SE - Svezia 773
IN - India 592
BR - Brasile 560
FR - Francia 557
UA - Ucraina 553
RU - Federazione Russa 498
IE - Irlanda 327
NL - Olanda 300
JP - Giappone 273
CI - Costa d'Avorio 227
BD - Bangladesh 216
TG - Togo 216
KR - Corea 201
FI - Finlandia 192
ZA - Sudafrica 184
EE - Estonia 144
CA - Canada 134
PH - Filippine 102
JO - Giordania 90
TH - Thailandia 86
BE - Belgio 81
CH - Svizzera 81
AR - Argentina 79
ID - Indonesia 75
HR - Croazia 74
BG - Bulgaria 73
AT - Austria 60
PL - Polonia 56
SC - Seychelles 50
NG - Nigeria 49
TW - Taiwan 48
MX - Messico 43
TR - Turchia 43
ES - Italia 42
SA - Arabia Saudita 41
IQ - Iraq 39
GR - Grecia 35
EU - Europa 34
AU - Australia 31
UZ - Uzbekistan 30
EC - Ecuador 29
PK - Pakistan 26
CL - Cile 23
CO - Colombia 23
LT - Lituania 22
RO - Romania 20
CZ - Repubblica Ceca 19
DZ - Algeria 15
EG - Egitto 15
IR - Iran 15
JM - Giamaica 15
MY - Malesia 15
MA - Marocco 14
VE - Venezuela 13
IL - Israele 12
KE - Kenya 12
LB - Libano 12
PE - Perù 12
PT - Portogallo 12
TN - Tunisia 11
AZ - Azerbaigian 10
CR - Costa Rica 10
PY - Paraguay 10
AE - Emirati Arabi Uniti 9
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
AL - Albania 7
DK - Danimarca 7
GT - Guatemala 7
NI - Nicaragua 7
SK - Slovacchia (Repubblica Slovacca) 7
GH - Ghana 6
HU - Ungheria 6
SV - El Salvador 6
TT - Trinidad e Tobago 6
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
NP - Nepal 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
ET - Etiopia 4
MD - Moldavia 4
OM - Oman 4
KH - Cambogia 3
LK - Sri Lanka 3
MN - Mongolia 3
PS - Palestinian Territory 3
SN - Senegal 3
AM - Armenia 2
BO - Bolivia 2
BW - Botswana 2
Totale 40.370
Salva come PNG Salva come JPEG
Città #
Singapore 2.376
Southend 2.005
Ashburn 1.329
Fairfield 1.279
Hong Kong 1.075
Chandler 939
San Jose 821
Ho Chi Minh City 678
Dong Ket 656
Wilmington 624
Santa Clara 585
Woodbridge 575
Seattle 566
Ann Arbor 543
Hanoi 529
Houston 499
Princeton 495
Bologna 454
Hefei 453
Cambridge 432
Council Bluffs 426
Beijing 425
Boardman 332
Dublin 318
Los Angeles 301
Jacksonville 285
Abidjan 227
Lauterbourg 220
Lomé 216
Tokyo 214
Dallas 202
Westminster 187
Milan 179
Padova 177
New York 175
Nanjing 173
Seoul 162
Helsinki 157
Berlin 152
Rome 152
Buffalo 137
Redmond 116
Saint Petersburg 102
San Diego 92
Jinan 91
Amman 88
Shanghai 84
São Paulo 83
Turin 83
Haiphong 78
Medford 76
Da Nang 75
Shenyang 73
The Dalles 73
Sofia 72
Bremen 71
Brussels 71
Florence 70
Frankfurt am Main 68
Guangzhou 66
Changsha 63
Redondo Beach 63
Nanchang 61
Hebei 60
Bern 58
Falls Church 58
Munich 58
Mülheim 58
Orem 58
Chicago 57
London 55
Atlanta 51
Toronto 51
Verona 51
Tianjin 48
Zhengzhou 47
Phoenix 45
Des Moines 44
Jiaxing 44
Bengaluru 43
Dearborn 43
Bangkok 42
Jakarta 39
Abeokuta 38
San Francisco 37
Vienna 34
Yubileyny 33
Shenzhen 32
Hangzhou 31
Mahé 31
Wuhan 31
Amsterdam 30
Brooklyn 30
Naples 30
Redwood City 30
Nuremberg 29
Biên Hòa 28
Ningbo 28
Hải Dương 27
Norwalk 27
Totale 24.985
Salva come PNG Salva come JPEG
Nome #
Interazioni tra sistema serotoninergico e mediatori dell'infiammazione nella fisiopatologia della sindrome dell'intestino irritabile 800
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. 493
Triptans and gastric accommodation: pharmacological and therapeutic aspects 487
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 439
Pro-arrhythmic potential of oral antihistamines (H1): Combining adverse event reports with drug utilization data across Europe 364
Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems 349
Adopting STOPP/START Criteria Version 3 in Clinical Practice: A Q&A Guide for Healthcare Professionals 328
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 325
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage 315
Escherichia coli Nissle 1917 restores epithelial permeability alterations induced by irritable bowel syndrome mediators 315
Data Mining Techniques in Pharmacovigilance: Analysis of the Publicly Accessible FDA Adverse Event Reporting System (AERS) 310
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 292
Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems 282
Adverse cardiovascular events associated with triptans and ergotamines for treatment of migraine: Systematic review of observational studies 281
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 276
Appropriateness of Proton Pump Inhibitor (PPI) prescription in patients admitted to hospital: Attitudes of general practitioners and hospital physicians in Italy 263
hERG-related drug toxicity and models for predicting hERG liability and QT prolongation 261
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 261
Farmacologia. Azioni e Reazioni dei farmaci. 252
Elementi di Farmacologia: Compendio per l’esame. 247
Switching among Equivalents in Chronic Cardiovascular Therapies: 'Real World' Data from Italy 247
Antipsychotics and Torsadogenic Risk: Signals Emerging from the US FDA Adverse Event Reporting System Database. 245
Diagnosis and therapy of irritable bowel syndrome 244
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System 241
Nerve fiber outgrowth is increased in the intestinal mucosa of patients with irritable bowel syndrome 241
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System 239
Drug-Induced Renal Damage in Preterm Neonates: State of the Art and Methods for Early Detection 239
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 239
Pattern of drug use among preterm neonates: Results from an Italian neonatal intensive care unit 238
Advancements in drug development for diarrhea-predominant irritable bowel syndrome 237
Exploring the underlying mechanisms of drug-induced impulse control disorders: a pharmacovigilance-pharmacodynamic study 235
Risk of hospitalization from drug-drug interactions in the Elderly: real-world evidence in a large administrative database 235
beta3-adrenoceptors in the gut: evidence for a possible role in enteric neuroimmunomodulation 232
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 230
Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent 228
Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. 224
Antibacterial macrolides: a drug class with a complex pharmacological profile 223
Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database 223
Predictors of antipsychotic prescription in a Northern Italian District (Bologna) 220
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 218
Animal models of chemically induced intestinal inflammation: Predictivity and ethical issues 218
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursement 216
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage. 216
Antimicrobials and the Risk of Torsades de Pointes. The Contribution from Data Mining of the US FDA Adverse Event Reporting System 214
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 211
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 209
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 206
Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats. 205
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 205
Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System 203
Addition of dipeptidyl peptidase-4 inhibitors to sulphonylureas and risk of hypoglycaemia: systematic review and meta-analysis 200
Use of phytoestrogens and effects perceived by postmenopausal women: result of a questionnaire-based survey 199
Social and clinical descriptors of antipsychotic prescription 197
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 197
Posterior Reversible Encephalopathy Syndrome Associated With Licorice Consumption: A Case Report in a 10-Year-Old Boy 194
Drug-induced Kounis syndrome: A matter of pharmacovigilance 194
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project 193
Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. 192
Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications 192
Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment 192
An update on the first decade of the European centralized procedure: how many innovative drugs? 190
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 190
Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis 188
Paraneoplastic Syndrome 187
Cardiovascular events in statin recipients: impact of adherence to treatment in a 3-year record linkage study 187
Clinically important drug-drug interactions in poly-treated elderly outpatients: A campaign to improve appropriateness in general practice 187
Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing 187
Disproportionality signal of progressive multifocal leukoencephalopathy: monoclonal antibodies versus other immunosuppressants 186
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug development 185
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 185
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 184
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 184
Strategies and Tools for Supporting the Appropriateness of Drug Use in Older People 183
Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics 183
Detection of D-penicillamine in skin lesions in a case of dermal elastosis after a previous long-term treatment for Wilson's disease 181
Case Report. 181
Using artificial intelligence to create diverse and inclusive medical case vignettes for education 180
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 180
Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats. 178
5-HT7 Receptors Modulate Peristalsis and Accommodation in the Guinea Pig Ileum 176
Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats 176
Dapagliflozin and cardiovascular outcomes: anything else to DECLARE? 176
QT interval shortening in spontaneous reports submitted to the FDA: the need for consensus 174
Enteric neuroplasticity evoked by inflammation 174
Academic output from EU-funded health research projects 173
The hERG K+ channel: target and antitarget strategies in drug development. 172
A clinical pharmacology and therapeutics teacher's guide to race-based medicine, inclusivity, and diversity 169
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance 168
Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System. 167
Mesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterology 167
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 166
Delayed gastric emptying in functional dyspepsia 165
La condivisione dei trattamenti farmacologici in psichiatria e la percezione degli effetti avversi ai farmaci antipisicotici da medico, paziente e familiare 164
Farmaci lassativi e purganti 163
Excipients in medicinal products used in gastroenterology as a possible cause of side effects. 163
Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective 163
L'essenziale in Farmacologia Clinica 162
Fattori determinanti nell'utilizzo dei farmaci antipsicotici 162
Inflammatory neuropathies of the enteric nervous system 160
Use and Perception of Phytoestrogens in Postmenopausal Women: Result of a Questionnaire-Based Survey 159
Totale 22.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.021
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.927 0 147 257 225 361 275 185 276 176 228 1.084 713
2022/20234.512 446 555 300 564 309 314 211 286 764 194 388 181
2023/20241.573 129 218 141 167 151 239 67 116 54 113 105 73
2024/20255.333 296 866 619 296 843 319 349 202 142 316 172 913
2025/202613.124 955 1.093 1.206 844 1.429 761 1.724 405 2.424 1.014 742 527
2026/20271.694 935 759 0 0 0 0 0 0 0 0 0 0
Totale 41.160